Correlation Between Neurobiological Technologies and Exelixis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurobiological Technologies and Exelixis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobiological Technologies and Exelixis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurobiological Technologies and Exelixis, you can compare the effects of market volatilities on Neurobiological Technologies and Exelixis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobiological Technologies with a short position of Exelixis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobiological Technologies and Exelixis.

Diversification Opportunities for Neurobiological Technologies and Exelixis

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Neurobiological and Exelixis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Neurobiological Technologies and Exelixis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exelixis and Neurobiological Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobiological Technologies are associated (or correlated) with Exelixis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exelixis has no effect on the direction of Neurobiological Technologies i.e., Neurobiological Technologies and Exelixis go up and down completely randomly.

Pair Corralation between Neurobiological Technologies and Exelixis

If you would invest  1,935  in Exelixis on August 31, 2024 and sell it today you would earn a total of  1,711  from holding Exelixis or generate 88.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy5.88%
ValuesDaily Returns

Neurobiological Technologies  vs.  Exelixis

 Performance 
       Timeline  
Neurobiological Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neurobiological Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong forward indicators, Neurobiological Technologies is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.
Exelixis 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Exelixis are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical and fundamental indicators, Exelixis disclosed solid returns over the last few months and may actually be approaching a breakup point.

Neurobiological Technologies and Exelixis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurobiological Technologies and Exelixis

The main advantage of trading using opposite Neurobiological Technologies and Exelixis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobiological Technologies position performs unexpectedly, Exelixis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exelixis will offset losses from the drop in Exelixis' long position.
The idea behind Neurobiological Technologies and Exelixis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios